Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-27 4:15 pm Purchase |
2025-01-22 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
S.H.N. Financial Investments Ltd. | 21,218 9.990% |
21,218 (New Position) |
Filing History |
| 2025-01-24 8:32 pm Purchase |
2025-01-21 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
BIGGER CAPITAL FUND L P | 21,218 9.990% |
21,218 (New Position) |
Filing History |
| 2024-11-14 4:07 pm Sale |
2024-09-30 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Armistice Capital, LLC | 6,091 4.990% |
-2,269 (-27.14%) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Armistice Capital, LLC | 8,360 8.670% |
8,360 (New Position) |
Filing History |
| 2022-02-14 06:05 am Sale |
2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Altium Capital Management LLC | 0 0.000% |
-4,500 (Position Closed) |
Filing History |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
The Vanguard Group | 3,326 4.360% |
1,597 (+92.41%) |
Filing History |
| 2022-01-19 10:48 am Sale |
2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 336 0.440% |
-3,664 (-91.61%) |
Filing History |
| 2022-01-03 5:57 pm Sale |
2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
SABBY MANAGEMENT LLC | 604 11.000% |
-4,396 (-87.92%) |
Filing History |
| 2021-02-24 10:46 am Purchase |
2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Altium Capital Management LLC | 4,500 5.900% |
4,500 (New Position) |
Filing History |
| 2021-02-19 2:45 pm Purchase |
2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
SABBY MANAGEMENT LLC | 5,000 11.000% |
4,417 (+757.14%) |
Filing History |
| 2021-02-18 10:49 am Purchase |
2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 4,000 5.250% |
3,664 (+1091.38%) |
Filing History |
| 2021-02-16 09:59 am Purchase |
2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
CVI Investments, Inc. | 420 1.300% |
236 (+128.84%) |
Filing History |
| 2021-02-10 10:57 am Purchase |
2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
The Vanguard Group | 1,729 5.960% |
1,729 (New Position) |
Filing History |
| 2021-02-09 3:50 pm Purchase |
2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Hudson Bay Capital Management LP | 296 0.920% |
2 (+0.76%) |
Filing History |
| 2021-01-20 11:10 am Sale |
2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 336 1.050% |
-1,664 (-83.21%) |
Filing History |
| 2021-01-07 1:38 pm Sale |
2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
SABBY MANAGEMENT LLC | 583 11.000% |
-1,417 (-70.84%) |
Filing History |
| 2020-12-28 4:57 pm Sale |
2020-12-23 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
HIRSCHMAN ORIN | 1,173 4.000% |
-827 (-41.34%) |
Filing History |
| 2020-12-09 06:49 am Purchase |
2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
HIRSCHMAN ORIN | 2,000 6.900% |
2,000 (New Position) |
Filing History |
| 2020-12-02 11:12 am Purchase |
2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 2,000 6.910% |
2,000 (New Position) |
Filing History |
| 2020-12-01 8:48 pm Purchase |
2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
SABBY MANAGEMENT LLC | 2,000 11.000% |
2,000 (New Position) |
Filing History |